News & Events

News & Events

  News Date News
  25-01-2011 Surya Pharmaceutical Ltd. is now ASSOCHAM member
    Surya Pharmaceutical Limited has joined The Associated Chambers of Commerce & Industry of India (ASSOCHAM) as a Corporate Associate Member.

ASSOCHAM is a national level platform to deliberate upon key subjects ranging from Audit/Governance/Markets/Taxes/Education to Economic affairs and garner cross-industry knowledge sharing/interface by all its Corporate Members.

  29-12-2010 SPL Acquires US based OTC analgesic drug brand
    The Tribune (12-28-2010) , The Times Of India, HT Live, Financial Express (11-09-2010), Economic Times, Business Line (12-28-2010), Dainik Bhaskar, Ajit (12-25-2010), Amar Ujala
  Dec, 2010 SPL in the Acquisition Mode!
    After demonstrating astounding business growth by ranking in the top Fortune 500 companies in India, the 20th largest Pharmaceutical firm in India as well as one of ET 500 companies recently, Surya Pharmaceutical Limited (SPL), is on its march to rapid glory via massive national and international expansion.

The Company has acquired the US-based Over-the-Counter (OTC) analgesic drug brand Activon for $ 22 million (Rs 99.52 crore). The deal has provided SPL the established US market of Activon and global marketing rights. The brand comes with the acquisition of Ameshire Investment Corp USA.

Activon is a leading OTC analgesic brand in the topical analgesic category in the US market. It is used to provide relief of joint and muscle pain associated with arthritis, backache, strains, bruises and sprains. Through the acquisition, the Company also adds to its portfolio brands namely Preferon, First On and Renewin. It would also have global marketing rights for Head On, another leading brand (except USA).

The acquisition provides SPL with a strategic competitive advantage to market our products in US through established market networking channels that include leading retailers like Walmart, Walgreen, CVS, Rite Aid etc. This also provides an opportunity to launch our OTC / FMCG products in US markets.

With the latest developments the shares of the company have shot up by 5.73% at the BSE.

  23-12-2010 SPL ranks 398 in the prestigious FORTUNE India 500 list & Ranked no: 20 in Indian Pharmaceutical Sector
    SPL has ranked 398 in the prestigious FORTUNE India 500 list! The Fortune India 500 list features India`s LARGEST CORPORATIONS!

Not only that, it outranked Pharmaceutical giants like Aventis Pharma, Alembic, Arch Pharmalabs and Ankur Drugs to climb to number 20 in the top Drugs & Pharmaceuticals companies of India!

Companies in the Fortune 500 list are ranked on the parameters of both Revenue & Income, they are ranked by their latest annual audited total income for the financial year ending on or before June 30, 2010. The Total Income includes Core Operating Income ( Net sales) plus other Extraordinary Income. Audited results declared before October 31st, 2010 have been used for the calculations. The numbers have been sourced from two corporate databases- the Centre for Monitoring of Indian Economies Prowess and Capitaline Plus by Capital Market Publishers India.
  29-10-2010 Ranking & Milestones
    The prestigious Inc Magazine has ranked Surya Pharmaceutical Limited at the 77th rank among the top 500 best performing enterprises in India.

More more

  16-10-2010 State-of-the-art Manufacturing facility commissioned at Samba Plant, Jammu!
    SPL launches new state-of-the-art Manufacturing facility at Samba plant, Jammu. This newly commissioned facility comprises two independent manufacturing streams. While Manufacturing Stream A - is a dedicated facility for Non Sterile, APIs and Intermediates, Manufacturing Stream B- is designed to cater to upcoming Sterile API Facility.

More more

  08-10-2010 Surya BioPharma USA Inc., San Diego, USA
    State-of-the-art R & D facility launched in USA! Surya BioPharma USA Inc., a subsidiary of Surya Pharmaceutical Ltd. begins operations in San Diego!

More more

  25-09-2010 Private Label range on the horizon!
    We are planning to launch our own brands under the Private Label Range which includes OTC Products— Cotton Buds, Cotton Balls...

More more

  23-09-2010 Surya BioPharma USA Inc. to be launched!
    Our US based R&D facility, Surya BioPharma USA Inc., a subsidiary of Surya Pharmaceutical Limited is being readied for launch...

More more

  11-09-2010 Surya Melange for Leh victims
    Surya sponsored SURYA MELANGE, a cultural evening presented by singer Ms Rinku Kalia...

More more

  11-09-2010 Surya Melange an evening of Ghazal & Geet by Rinku Kalia
    The Tribune (12-09-2010), Hindustan Times (12-09-2010), Hindustan Times (11-09-2010), Yugmarg (11-09-2010), Dainik Bhaskar (11-09-2010), Dainik Bhaskar (11-09-2010), Dainik Jagran (11-09-2010), Dainik Jagran (12-09-2010), Dainik Tribune (12-09-2010), Dainik Bhaskar (12-09-2010), Chandigarh Kesari (12-09-2010), Amar Ujala (11-09-2010), Amar Ujala (12-09-2010), Hindustan (12-09-2010), Chandigarh Dinbhar (10-09-2010), Punjab Kesari (11-09-2010), Aaj Samaj (11-09-2010), Rozana Spokesman (11-09-2010), Jagbani (12-09-2010), Desh Sewak (11-06-2010), Ajit (11-09-2010)

Click here to view Photo Gallery more

  09-09-2010 The European Directorate of Quality in Medicine & Healthcare
    EDQM has granted SPL our DMF number for our product– Cefuroxime Axetil ( CEP2010-250)
  07-09-2010 to
10-09-2010
VIVA numbers increase, Camps galore!
    VIVA added five more stores to its kitty in Delhi. Not just that, it also organized more than 25 health camps in the capital...

More more

  15-08-2010 Independence Day - Message & Celebrations
    August 15th; Independence day was celebrated at the Surya World Campus as well as the Formulations office in Sector 7...

More more

Click here to view Photo Gallery more

  10-08-2010 Health Camps & stores galore at VIVA
    VIVA now has as many as 57 stores to its credit. Out of these , 40 are successfully operational in Delhi and NCR...

More more

  08-08-2010 New products
    Bl-cycloketone ( an intermediate) and Thiocolchicoside ( API) have been developed and are being supplied commercially...

More more

  29-07-2010 Formulations Marches Forward!
    Formulations has received its first bulk overseas order and is all set to deliver the same very soon. Congratulations to all!

More more

  25-07-2010 Surya holds Annual Badminton Tournament!
    A Badminton Tournament was organised by Surya Pharmaceutical Limited on 25th July at the Sports Complex ,Sector 42, Chandigarh...

More more

  22-07-2010 Sulphide has been launched commercially
    Sulphide has been launched commercially. We are in the process of tying up with International Brands like Palmars

More more

  22-07-2010 Crown of Brilliance
   

A Crown of Brilliance for Innovation was awarded to SPL by a Japanese Company called SHIMADZU.
Quinidine

  20-07-2010 Formulations Marches Ahead!
    In its second phase, our Formulations Division has expanded to cover more states such as Maharashtra, Rajasthan...

More more

  19-07-2010 -
21-07-2010
SPL participates in INDO-CIS Pharma Business Meet
    T h e I n d o - C I S Pharma Business Meet was held in Mumbai from 19th to 21st July, 2010...

More more

  15-07-2010 Viva turns 50 strong!
    With the launch of the 50th VIVA store at Vijay Nagar, Delhi,VIVA has reached the half century mark ...

More more

  11-06-2010 Wellness outlet opens
    The Tribune, The Financial World, Business Standard, Hindustan Times, Yugmarg, Punjab Kesari, Hindustan, Dainik Bhaskar, Aap Ka Faisla, Aaj Samaj, Dainik Jagran, Dainik Tribune, Arth Prakash, Ajit, Chardikala, Aj di Awaaz
  26-05-2010 Surya Pharma and CROCS tie up
    click to view
  11-03-2010 Viva outlet opens in Sec-44 Chandigarh
    Hindustan Times, The Financial World, Punjab Kesari, Hindustan, Amar Ujala, Dainik Bhaskar, Dainik Tribune
  10-02-2010 273 examined at health camp
    The Tribune (09-02-2010), The Indian Express (09-02-2010), Hindustan-Times (10-02-10), Hindustan (10-02-10), Dainik Bhaskar (10-02-10), Dainik Tribune (09-02-10), Arth Parkash (09-02-10), Dainik Jagran (09-02-10), Aaj Samaj (09-02-10), Jagbani (09-02-10), Punjab Kesari (09-02-10)
  17-01-2010 Viva stores come to the Tri-City
    The Tribune, Yugmarg (11-01-2010), The Indian Express (13-01-2010) , Hindustan Times (12-01-2010) , Dainik Bhaskar (12-01-2010), Divya Himachal (12-01-2010) , Ajit Samachar (12-01-2010) , Aaj Samaj (12-01-2010) , Dainik Tribune (12-01-2010) , Arth Parkash (11-01-2010), Dainik Jagran (12-01-2010) , Nawan Zamana (12-01-2010) , Ajit (12-01-2010), Rozana Spokesman (15-01-2010)
  01-05-2009

Mr Rajiv Goyal Managing Director, Surya Corp

Mr Rajiv Goyal is the dynamic Chairman and Managing Director of Surya Corp of Companies, a fast emerging conglomerate based in North India. This go getter exhibited the true spirit of entrepreneurship when he dared to take up the challenge of moving from the family run business of electrical goods, metals and textiles to the business of pharmaceuticals

More more

  01-05-2009

Star of the month Rajiv Goyal

In these days global meltdown, Tricity comes in contact with Chandigarh's Rajiv Goyal of Surya Pharmaceuticals Limited who is finiding ways to hire personnel for his ever-expanding health-care outlets. His enterprising spirit makes him the star of the month.

More more

  25-03-2009

Surya to set up ‘wellness’ chain of 500 stores under ‘Viva’ brand name (IndiaRetailBiz)

Surya Pharmaceutical, a Chadigarh-based pharmaceuticals manufacturer, owned by Rajiv Goyal, is foraying into Wellness Retail. The company has chosen the brand name of ‘Viva’ for its proposed retail chain of healthcare and medicines stores.

More more

  25-03-2009 Surya to enter Retail Pharma (Business Bhaskar Chandigarh)
  24-03-2009

Surya Retail Education (The Financial Express New Delhi)

Chandigarh-based pharmaceutical company Surya Pharmaceutical(turnover in 2007-08:Rs508 crore) plans to invest close to Rs 250 crore to venture into retail and education as well as to expand its pharmaceutical business in fiscal 2009-10.

More more

  24-03-2009 Surya Pharmaceutical Limited has submitted to the Exchange a copy of disclosure under Regulation 8A (4) of SEBI (Substantial Acquisition of Shares and Takeovers) (Amendment) Regulation, 2009. A copy of the same shall be available on the NSE website(http://www.nseindia.com)under: Corporates > Latest Announcements
  17-03-2009 Surya Pharmaceutical Limited has submitted to the Exchange a copy of the proceedings of the Extra Ordinary General Meeting of the Company held on March 14, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under Corporates > Latest Announcements
  25-02-2009 Surya Pharmaceutical Limited has submitted to the Exchange a copy of the notice of the Extraordinary General Meeting of the members of the Company to be held on March 14, 2009. The copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements
  29-01-2009 Surya Pharmaceutical Limited has informed the Exchange that the Board of Directors of the Company in their meeting held on January 29, 2009. (1) Subject to the approval of the shareholders, the company has resolved to increase the authorised capital of the Company from Rs.26.00 Crores, divided into 2,60,00,000 Equity Shares of Rs.10/- each to Rs.50.00 Crores, divided into 5,00,00,000 Equity Sahres of Rs.10/- each. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements

 

  sgs logo
  satymev-qa halal-jas
  edqm-ies